May 2015 Issue of The Ophthalmologist

Last year, we berated ourselves for the disappointing show of women in our Top 100 Power List (a measly 13 percent). So, how did we do in our Top 40 Under 40?

VR headsets could identify those with glaucoma at the greatest risk of falls

Preoperative evaluation is not recommended for patients about to undergo cataract surgery – so why are ophthalmologists in the US continuing to order costly tests?

Thermography could offer a noninvasive way of assessing bleb function

Draft guidelines released by the FDA clarifies what foreign device study data it will accept

Measuring refractive error at six years of age may be the best way to predict which children will go on to become myopes

Second corneal transplants are far more likely to be rejected than first-time grafts – but now that we know why, we might be able to prevent it

Methamphetamine manufacturers with work-related ocular injuries have particularly poor outcomes

Ophthalmic surgery that incorporates robotic assistance holds the promise of surgeries that are “better than the best of humans”

Femtosecond laser-assisted cataract surgery in eyes with small pupils can be tricky and fraught with problems. Pupil expansion devices can help overcome them.

An illuminated sleep mask that exploits the Troxler effect might transform the treatment of diabetic retinopathy

A naturally-occurring proteogylcan, decorin, can effect CXL-like biomechanical changes when applied to ex-vivo human and porcine corneas.

Gene and stem cell therapies hold the promise of restoring vision in patients with retinal diseases – but who should be paying for these treatments, and how?

Sitting Down With… Bala Ambati, Professor of Ophthalmology, Moran Eye Center, University of Utah, UT, USA.

OCT angiography (OCT-A) is poised to augment, and in many cases, replace traditional methods of examining the retinal and choroidal vasculature – once certain technical challenges are addressed.

As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.

Managing dry eye disease becomes disproportionately more difficult as the severity of the disease increases: artificial tears and lubricants are not enough to help patients with severe dry eye disease.